Novo Nordisk to invest over 17 billion DKK in Kalundborg manufacturing facilities

Novo Nordisk announced plans to invest more than 17 billion Danish kroner in constructing three new manufacturing facilities and expanding one existing facility at its production site in Kalundborg, Denmark, adding capacity for API, assembly, and packaging.

“This major investment in our manufacturing facilities in Kalundborg is an important step in building and ensuring future capacity for production of our current and future oral and injectable product portfolio.”nordiclifescience.org

• 1 source
• nordiclifescience.orgNovo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - NLSMalin OtmaniDec 13, 2021

Summarized from public sources; check the original articles before acting on it.